Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 137215-12-4
2. Odiparcil [inn]
3. Fik1414zi8
4. Gsk 424323
5. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-
6. 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one
7. Odiparcil [who-dd]
8. Dsstox_cid_31428
9. Dsstox_rid_97314
10. Unii-fik1414zi8
11. Dsstox_gsid_57639
12. Schembl4515803
13. Chembl2107763
14. Dtxsid4057639
15. Tox21_113853
16. Zinc31597280
17. 4-methyl-7-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one
18. Db06609
19. Gsk-424323
20. Ncgc00253734-01
21. Bo167288
22. Sb 424323
23. Cas-137215-12-4
24. E98880
25. Q27278001
26. 4-methyl-7-(5-thio-beta-d-xylopyranosyloxy)-2h-chromen-2-one
27. 4-methyl-2-oxo-2h-1-benzopyran-7-yl 5-thio-beta-d-xylopyranoside
28. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-b-d-xylopyranosyl)oxy]-
29. 4-methyl-7-(5-thio-.beta.-d-xylopyranosyloxy)-2h-chromen-2-one
30. 7-((2r,3r,4s,5s)-tetrahydro-3,4,5-trihydroxy-2h-thiopyran-2-yloxy)-4-methyl-2h-chromen-2-one
| Molecular Weight | 324.4 g/mol |
|---|---|
| Molecular Formula | C15H16O6S |
| XLogP3 | 0.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 324.06675940 g/mol |
| Monoisotopic Mass | 324.06675940 g/mol |
| Topological Polar Surface Area | 122 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 467 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in atrial fibrillation, cardiovascular disorders, thrombosis, and venous thromboembolism.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
73
PharmaCompass offers a list of Odiparcil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Odiparcil manufacturer or Odiparcil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Odiparcil manufacturer or Odiparcil supplier.
PharmaCompass also assists you with knowing the Odiparcil API Price utilized in the formulation of products. Odiparcil API Price is not always fixed or binding as the Odiparcil Price is obtained through a variety of data sources. The Odiparcil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Odiparcil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Odiparcil, including repackagers and relabelers. The FDA regulates Odiparcil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Odiparcil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Odiparcil supplier is an individual or a company that provides Odiparcil active pharmaceutical ingredient (API) or Odiparcil finished formulations upon request. The Odiparcil suppliers may include Odiparcil API manufacturers, exporters, distributors and traders.
Odiparcil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Odiparcil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Odiparcil GMP manufacturer or Odiparcil GMP API supplier for your needs.
A Odiparcil CoA (Certificate of Analysis) is a formal document that attests to Odiparcil's compliance with Odiparcil specifications and serves as a tool for batch-level quality control.
Odiparcil CoA mostly includes findings from lab analyses of a specific batch. For each Odiparcil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Odiparcil may be tested according to a variety of international standards, such as European Pharmacopoeia (Odiparcil EP), Odiparcil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Odiparcil USP).
